Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality

Affiliations

Department of Ophthalmology and Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States; Sight for Souls, Bellevue, Washington, United States; MCM Eye Unit, MyungSung Christian Medical Center General Hospital and MyungSung Medical School, Addis Ababa, Ethiopia; Department of Ophthalmology, Addis Ababa University School of Medicine, Addis Ababa, Ethiopia; Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, United States; Center for Occupational Biostatistics and Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, United States; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, United States; Wilmer Eye Institute, Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States; Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, United States; Portland Veteran's Affairs Medical Center, Portland, Oregon, United States; Department of Medicine, Oregon Health and Science University, Portland, Oregon, United States; Legacy Devers Eye Institute, Portland, Oregon, United States; Department of Ophthalmology, George Washington University, Washington, District of Columbia, United States; Janssen Retina Global Clinical Development, Princeton, New Jersey, United States; Department of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, United States; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, United States; Cole Eye Institute, Department of Ophthalmology, Cleveland Clinic, Cleveland, Ohio, United States; Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States; Illinois Eye & Ear Infirmary, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States; F.I. Proctor Foundation, Department of Ophthalmology, University of California San Francisco School of Medicine, San Francisco, California, United States; Ocular Inflammatory Disease Center, Jules Stein Eye Institute, Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California, United States; Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States; Mid-Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania, United States; Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States; Department of Ophthalmology, Somdech Phra Pinkloa Hospital, Royal Thai Navy, Bangkok, Thailand; Department of Ophthalmology, Chulalongkorn University, Bangkok, Thailand; Mahatme Eye Bank Eye Hospital, Maharashtra, Nagpur, India; Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, United States; Santen Inc., Emeryville, CA, United States; Siddharth Netralaya Superspecialty Eye Hospital, Karnataka, Belgaum, India; Department of Neurology, Northwell Health, Staten Island, New York, United States; University of Rochester School of Medicine & Dentistry, Rochester, New York, United States